Company / EPS (Diluted)
Warby Parker Inc. EPS (Diluted) History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
-$0.54
FY2025
5-year range
-$2.21 / -$0.54
FY2021-FY2025
Trend
+43.7%
vs FY2024
Sector context
#110 of 159
Health Care
What the data says
At $-0.54, Warby Parker Inc.'s eps (diluted) ranks #110 of 159 in the Health Care sector. EPS (Diluted) has fluctuated over the past 7 years, ranging from $-2.21 in FY2023 to $-0.54 in FY2025.
Based on SEC 10-K filings.
-0.54 in FY2025.
Improved from $-2.21 to $-0.54 over the past 2 years.
Health Care sector context is included.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#110 of 159 in Health CareTop 69% of 159This company -$0.54 Sector average $1.56
▼
-134.7% below sector average
Key checks
Key Insights
- In FY2025, eps (diluted) increased 43.7% year-over-year.
- Ranks #110 out of 159 companies in the Health Care sector.
- Lowest eps (diluted) in the period was in FY2023.
Company context
Key Data Points
- Altman Z-Score 1.02 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$0.54 | +43.7% |
| FY2024 | -$0.96 | +56.6% |
| FY2023 | -$2.21 | -110.5% |
| FY2022 | -$1.05 | +4.5% |
| FY2021 | -$1.10 | -4.8% |
| FY2020 | -$1.05 | +4.5% |
| FY2019 | -$1.10 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026